Position in INCY
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$34,114,358
-$2,156,850 QoQ
Shares Held
362,456
-1.3% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swedbank AB holds $1,230,784,492 across 20 Biotechnology names. INCY ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
11,586,693 | $555,813,663 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
992,108 | $187,558,017 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
215,590 | $166,573,457 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
271,553 | $121,259,276 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
792,187 | $44,750,643 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $36,103,858 | |
| 7 | INCY |
Incyte Corp
This page
|
362,456 | $34,114,358 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
62,215 | $20,585,076 |
All Filings in INCY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,114,358 | 362,456 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $36,271,208 | 367,229 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $31,537,107 | 371,856 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $41,629,121 | 611,294 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $39,191,975 | 567,424 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $44,032,250 | 666,146 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $40,385,771 | 666,212 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $37,440,285 | 657,193 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $39,741,988 | 632,935 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $35,235,713 | 609,931 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $35,112,610 | 564,058 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $40,764,471 | 564,058 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $45,305,138 | 564,058 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $37,588,825 | 564,058 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $43,689,739 | 575,092 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $45,467,314 | 572,492 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $41,045,867 | 559,208 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $38,462,326 | 559,208 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $47,046,169 | 559,208 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $52,885,721 | 650,741 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||